An Open-Label, Long-Term Study of Telmisartan Plus Amlodipine Fixed-Dose Combination.

Trial Profile

An Open-Label, Long-Term Study of Telmisartan Plus Amlodipine Fixed-Dose Combination.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2013

At a glance

  • Drugs Amlodipine/telmisartan (Primary)
  • Indications Essential hypertension
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 21 Dec 2012 Results from this trial have been reported in an Astellas Pharma and Boehringer Ingelheim Nippon media release.
    • 13 Oct 2010 A Boehringer Ingelheim media release states the EMEA has approved telmisartan/amlodipine for the treatment of hypertension in adults.
    • 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top